Przedstawiamy wybór publikacji naukowych związanych z immunoterapią IOZK. Możesz użyć filtrów, aby dokonać wyboru według typów nowotworów i metod lub wprowadzić wyszukiwane hasła.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-12-01 / Int. J. Hematol. 2006 Dec;84(5):449-58https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-12-01 / Int. J. Hematol. 2006 Dec;84(5):449-582006-12-01 00:00:002019-02-15 08:48:21Combined use of dendritic cells enhances specific antileukemia immunity by leukemia cell-derived heat shock protein 70 in a mouse model with minimal residual leukemia cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-12-01 / J Clin Apher 2006 Dec;21(4):233-40https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-12-01 / J Clin Apher 2006 Dec;21(4):233-402006-12-01 00:00:002019-02-15 08:32:37Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-12-01 / Int J Hyperthermia 2006 Dec;22(8):699-712https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-12-01 / Int J Hyperthermia 2006 Dec;22(8):699-7122006-12-01 00:00:002019-02-15 08:35:06Artificial cytokine storm combined with hyperthermia induces significant anti-tumor effect in mice inoculated with lewis lung carcinoma and B16 melanoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-11-28 / Cancer Immunol. Immunother. 2007 Jul;56(7):1025-36https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-11-28 / Cancer Immunol. Immunother. 2007 Jul;56(7):1025-362006-11-28 00:00:002019-02-15 08:38:12Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-11-28 / Zhonghua Yi Xue Za Zhi 2006 Nov;86(44):3122-7https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-11-28 / Zhonghua Yi Xue Za Zhi 2006 Nov;86(44):3122-72006-11-28 00:00:002006-11-28 00:00:00[Immune response of heparinase gene modified dendritic cell-based vaccine on gastric cancer cells]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-11-15 / Int. J. Cancer 2006 Nov;119(10):2428-34https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-11-15 / Int. J. Cancer 2006 Nov;119(10):2428-342006-11-15 00:00:002019-02-15 09:24:12Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-11-01 / Gan To Kagaku Ryoho 2006 Nov;33(12):1739-41https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-11-01 / Gan To Kagaku Ryoho 2006 Nov;33(12):1739-412006-11-01 00:00:002019-02-15 08:44:38[Successful immunotherapy combined with hyperthermia therapy for cancer patients]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-11-01 / Cancer Res. 2006 Nov;66(21):10247-52https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-11-01 / Cancer Res. 2006 Nov;66(21):10247-522006-11-01 00:00:002019-02-15 08:59:57Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-11-01 / In Vivo 2006 Nov-Dec;20(6A):721-4https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-11-01 / In Vivo 2006 Nov-Dec;20(6A):721-42006-11-01 00:00:002019-02-15 09:00:11A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-11-01 / Int J Hyperthermia 2006 Nov;22(7):613-21https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-11-01 / Int J Hyperthermia 2006 Nov;22(7):613-212006-11-01 00:00:002006-11-01 00:00:00Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-11-01 / In Vivo 2006 Nov-Dec;20(6A):689-95https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-11-01 / In Vivo 2006 Nov-Dec;20(6A):689-952006-11-01 00:00:002006-11-01 00:00:00Hyperthermia and immunity. A brief overview
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-10-26 / Mol. Cancer 2006 Oct;5:49https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-10-26 / Mol. Cancer 2006 Oct;5:492006-10-26 00:00:002019-02-15 08:35:27Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-10-23 / Clin. Immunol. 2007 Jan;122(1):18-27https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-10-23 / Clin. Immunol. 2007 Jan;122(1):18-272006-10-23 00:00:002019-02-15 08:52:20In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-10-10 / Cancer Immunol. Immunother. 2007 Apr;56(4):429-45https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-10-10 / Cancer Immunol. Immunother. 2007 Apr;56(4):429-452006-10-10 00:00:002019-02-15 09:24:12Vaccination therapy in prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002006-10-01 / Exp. Hematol. 2006 Oct;34(10):1403-12https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2006-10-01 / Exp. Hematol. 2006 Oct;34(10):1403-122006-10-01 00:00:002019-02-15 08:32:38Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses
Combined use of dendritic cells enhances specific antileukemia immunity by leukemia cell-derived heat shock protein 70 in a mouse model with minimal residual leukemia cells
Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy
Artificial cytokine storm combined with hyperthermia induces significant anti-tumor effect in mice inoculated with lewis lung carcinoma and B16 melanoma cells
Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma
[Immune response of heparinase gene modified dendritic cell-based vaccine on gastric cancer cells]
Antigen-independent immune responses after dendritic cell vaccination
Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival
[Successful immunotherapy combined with hyperthermia therapy for cancer patients]
Dendritic cell vaccination in patients with malignant gliomas: current status and future directions
Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
Recent advances in immunotherapy for human glioma
A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia
Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma
Hyperthermia and immunity. A brief overview
Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic cells
In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients
Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells
Vaccination therapy in prostate cancer
Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses
[Clinical impact of locoregional hyperthermia in gynecological oncology]